This inventor holds 1 USPTO granted patent. Top assignee: Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: John Haanen: Innovator in Cancer Research
Introduction
John Haanen is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer research, particularly in the development of innovative therapies. His work is focused on enhancing the effectiveness of cancer treatments through advanced methodologies.
Latest Patents
Haanen holds a patent for "T Cell Manufacturing Compositions and Methods." This patent represents a crucial advancement in the manufacturing of T cells, which are vital for immunotherapy in cancer treatment. His innovative approach aims to improve the efficacy of these therapies, potentially leading to better patient outcomes.
Career Highlights
John Haanen is affiliated with the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital. His role at this esteemed institution allows him to collaborate with leading experts in oncology and contribute to groundbreaking research. His dedication to cancer research has positioned him as a key figure in the field.
Collaborations
Haanen works alongside Marit M Van Buuren, a fellow researcher at the Netherlands Cancer Institute. Their collaboration focuses on advancing cancer treatment methodologies and exploring new avenues for immunotherapy.
Conclusion
John Haanen's contributions to cancer research through his patent and collaborative efforts highlight his commitment to improving cancer therapies. His work continues to inspire advancements in the field, making a significant impact on patient care.